You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

54 search results for: pediatric

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in <b>Pediatric</b> Patients

expert video

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in Pediatric Patients

15 min

Type 2 Inflammation

Dr. Leonard Bacharier presents potential disease trajectories and burden for pediatric patients with type 2 inflammatory diseases.

Understanding the Pathophysiology of <b>Pediatric</b> Type 2 Inflammatory Diseases

expert video

Understanding the Pathophysiology of Pediatric Type 2 Inflammatory Diseases

10 min

Type 2 Inflammation

Prof. Oscar Palomares discusses the underlying pathophysiology of type 2 inflammation in pediatric patients with AD, asthma, or EoE.

expert video

Managing Injection Pain in Children

1 min

Dermatology

Dr. Amy Paller explains how to manage injection pain in pediatric patients with atopic dermatitis.

expert video

High Burden of Atopic Dermatitis in Children

1 min

Dermatology

Explore the debilitating effects that impact day-to-day functioning in pediatric patients with atopic dermatitis – a short soundbite from EADV 2022.

expert video

Early Intervention in Children with Atopic Dermatitis: A Window of Opportunity?

38 min

Dermatology

Highlights from the ESPD 2023 ADVENT symposium, exploring burden, skin barrier normalization, and current treatments for pediatric atopic dermatitis.

expert video

Early Intervention in AD: Latest Clinical and Real-world Data

13 min

Dermatology

Highlights from ESPD 2023 ADVENT: Reviewing the current treatment landscape and the potential for early intervention in pediatric atopic dermatitis.

expert video

Current systemic therapies have been shown to induce remission in a subset of AD patients

5 min

Dermatology

Dr. Ramien discusses evidence suggesting early targeted inhibition in pediatric patients may prevent disease progression or lead to remission.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GreeceChange country/region